Immunoassays for immuno-oncology research
Move confdently across platforms
Visit our website to learn more about the ProcartaPlex
®
Human Immuno-oncology
Checkpoint Marker Panel and Platinum ELISA.
www.ebioscience.com/immuno-oncology
© 2016 Affymetrix, Inc. All rights reserved. For Research Use Only. Not for use in diagnostic procedures.
Immune checkpoints have come to the forefront of cancer therapies as a powerful and promising strategy to stimulate
anti-tumor T cell activity. Affymetrix provides a wide range of products for immuno-oncology research for the quantifcation
of these important checkpoint proteins. ProcartaPlex
®
Human Immuno-oncology Checkpoint Panel enables simultaneous
quantifcation of 14 checkpoint modulators. Speed, sensitivity, and specifcity make Platinum ELISA the method of choice
for biomarker evaluation.
Affymetrix offers multiple immunoassay platforms, providing the freedom to move from
a multiplex assay to an ELISA while producing comparable data.
98% correlation of antibody pairs across platforms
Lot-to-lot consistency for reliable reproducibility
Exceptional scalability between ProcartaPlex
®
assays and traditional Platinum ELISA